chrX-1288840-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000381529.9(CSF2RA):c.425C>T(p.Pro142Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00245 in 1,613,894 control chromosomes in the GnomAD database, including 87 homozygotes. There are 1,737 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P142Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000381529.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF2RA | NM_172245.4 | c.425C>T | p.Pro142Leu | missense_variant | 6/13 | ENST00000381529.9 | NP_758448.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF2RA | ENST00000381529.9 | c.425C>T | p.Pro142Leu | missense_variant | 6/13 | 1 | NM_172245.4 | ENSP00000370940 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0125 AC: 1904AN: 152124Hom.: 40 Cov.: 32 AF XY: 0.0119 AC XY: 885AN XY: 74312
GnomAD3 exomes AF: 0.00336 AC: 843AN: 251094Hom.: 19 AF XY: 0.00231 AC XY: 313AN XY: 135734
GnomAD4 exome AF: 0.00140 AC: 2040AN: 1461652Hom.: 47 Cov.: 34 AF XY: 0.00117 AC XY: 848AN XY: 727138
GnomAD4 genome AF: 0.0125 AC: 1907AN: 152242Hom.: 40 Cov.: 32 AF XY: 0.0119 AC XY: 889AN XY: 74440
ClinVar
Submissions by phenotype
Surfactant metabolism dysfunction, pulmonary, 4 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Mar 05, 2019 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 05, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Pro142Leu in exon 7 of CSF2RA: This variant is not expected to have clinical sig nificance because it has been identified in 4.8% (210/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs151058706). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at